Clinical Trials Logo

Clinical Trial Summary

The investigators will compare the operated patients for a beginning breast cancer in the Hypnose arm and the patient in the classical general anesthesia arm. It is a Observational study as we cannot randomized patient, (they need to be compliant with Hypnose).

Patient will be informed that some parameters, about his recovery, will be collected from their medical file. They will not have another particular treatment because they are in the study. It is just a prospective data collection.

The patient will be compared on several items after the surgery ( as pain and pain killer intake, the heal process of the scar, etc...) Also the investigators will compare the impact of hypnose on the other treatments the patient received.

The investigators need approximately 150 patients (Half in each arm).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03003611
Study type Observational
Source Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Contact
Status Completed
Phase N/A
Start date April 2014
Completion date September 2016

See also
  Status Clinical Trial Phase
Recruiting NCT05368428 - Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer N/A
Active, not recruiting NCT02212860 - Stereotactic Image-Guided Neoadjuvant Ablative Radiation Then Lumpectomy N/A
Terminated NCT02876640 - Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer Phase 1
Recruiting NCT05945290 - Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer
Recruiting NCT06387173 - Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer
Active, not recruiting NCT02167490 - Sentinel Node Vs Observation After Axillary Ultra-souND N/A
Recruiting NCT02889874 - EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer N/A
Active, not recruiting NCT02095743 - Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer Phase 2
Recruiting NCT06113016 - Prevention of Frailty With Fisetin and Exercise (PROFFi) in Breast Cancer Survivors Phase 2
Recruiting NCT05417867 - Association Between Changes in the Gut Microbiome and Chemotherapy-Induced Nausea in Stage I-III Breast Cancer